Dr Reddy's to market Biocodex products in Romania

Published On 2015-11-05 03:41 GMT   |   Update On 2021-08-10 08:45 GMT
Drug major Dr Reddy's Laboratories today said it has signed a pact with Biocodex to market the French-based firm's products in Romania.

The company has entered into a strategic alliance with Biocodex to market and distribute Biocodex products in the Romanian market, Dr Reddy's Laboratories said in a statement.

"Biocodex has announced the change in partnership and effective October 1, 2015, Dr Reddy's has been given the complete rights for promotion and distribution of the Biocodex products across
Romania
," it added.

Earlier, Akacia was in partnership with Biocodex for similar distribution pact.

Dr Reddy's will aim to develop the access of the Romanian patients to the Biocodex's product portfolio including its well-known over the counter products Enterol and Otipax, the company said.

Shares of Dr Reddy's were trading at Rs 4,355.00 apiece, up 0.68 per cent on BSE in afternoon trade.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News